Evidence map›Paper›PMID 38472685›Full record

ArticleDoklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections2023

Hydrogels Based on Recombinant Spidroin Stimulate Proliferation and Migration of Human Corneal Cells.

O I Agapova, D S Ostrovsky, M Kh Khubetsova, T Z Kerimov, S A Borzenok, V G Bogush, L I Davydova, S E Cheperegin, A E Efimov, I I Agapov and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

O I AgapovaAcademician Shumakov National Medical Research Center of Transplantology and Artificial Organs, Ministry of Health of the Russian Federation, Moscow, Russia.
D S OstrovskyFyodorov Eye Microsurgery Complex, Ministry of Health of the Russian Federation, Moscow, Russia.
M Kh KhubetsovaFyodorov Eye Microsurgery Complex, Ministry of Health of the Russian Federation, Moscow, Russia.
T Z KerimovFyodorov Eye Microsurgery Complex, Ministry of Health of the Russian Federation, Moscow, Russia.
S A BorzenokFyodorov Eye Microsurgery Complex, Ministry of Health of the Russian Federation, Moscow, Russia.
V G BogushKurchatov Institute National Research Center, Moscow, Russia.
L I DavydovaKurchatov Institute National Research Center, Moscow, Russia.
S E ChepereginKurchatov Institute National Research Center, Moscow, Russia.
A E EfimovAcademician Shumakov National Medical Research Center of Transplantology and Artificial Organs, Ministry of Health of the Russian Federation, Moscow, Russia.
I I AgapovAcademician Shumakov National Medical Research Center of Transplantology and Artificial Organs, Ministry of Health of the Russian Federation, Moscow, Russia. igor_agapov@gmail.com.
V G DebabovKurchatov Institute National Research Center, Moscow, Russia.
Kurchatov Institute · RUIntersectoral Research and Technology Complex Eye Microsurgery · RUV.I.Shumakov Federal Research Center of Transplantology and Artificial Organs · RUMinistry of Health of the Russian Federation · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The effect of recombinant spidroin (RS) hydrogel (HG) on anterior epithelial cells and keratocytes of the human cornea was studied in vitro. Corneal injuries are highly prevalent in developing countries according to the World Health Organization. Various technologies have recently been proposed to restore the damaged surface of the cornea. Use of biodegradable silk-based materials, including recombinant analogs of the spider silk protein spidroin, is an important avenue of research in the field of wound healing and corneal regeneration. Spidroins are well known for their optimal balance of strength and elasticity. Given their biological compatibility, lack of immunogenicity, and biodegradability, spidroins provide a biomaterial for tissue engineering and regenerative medicine. HGs based on RS rS2/12-RGDS were therefore tested for cytotoxicity toward isolated corneal epithelial cells and keratocytes with regard to possible changes in cell phenotype and migratory activity. A promising outlook and therapeutic potential were demonstrated for RS-based HGs.

Indexed as

FibroinsBiocompatible MaterialsCell ProliferationCorneaHumansSilkBiocompatible MaterialsFibroinsSilkcellscornearecombinant spidroinregenerationsilk

Identifiers

PMID38472685
OpenAlexW4392680461

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.